10 Affordable Weight Loss Medication Providers I’d Actually Pick in 2026
GLP-1 pricing is a mess right now, and most listicles just regurgitate brand marketing. Here is my honest ranked take on who is worth your money, based on cash pricing, pharmacy transparency, speed, and what the compounding regulatory shift actually means for your access.
1. HealthRX
Start here if price is the deciding factor. Compounded semaglutide runs $99 per month, compounded tirzepatide $149. Those are among the lowest cash prices I have seen from any telehealth platform with a named, verifiable pharmacy behind it. The medication ships from Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-level tracking. LegitScript certified (certificate 50087439). A board-certified physician reviews your intake within roughly 24 hours, and overnight shipping to all 50 states is included at no extra charge. The trial data HealthRX points to is real: SURMOUNT-1 showed tirzepatide averaging about 21% body weight reduction at 72 weeks, STEP 1 showed semaglutide around 15% at 68 weeks. These are compounded medications, not FDA-approved drugs, so understand that going in.
Best for: Cash-pay patients who want the lowest monthly cost and same-night shipping from an identifiable, certified pharmacy.
2. FormBlends
FormBlends sits one step up in price but adds something most GLP-1 platforms skip entirely: published per-product purity testing. HPLC purity percentages, mass spec identity confirmation, endotoxin and sterility results, all listed by product. Few providers in this space publish anything close to that level of detail. Compounded semaglutide runs around $299, tirzepatide around $349, dispensed through an FDA-registered 503A compounding pharmacy with physician oversight throughout. Ships to 47 states. It also carries a wider peptide catalog covering recovery, longevity, and cognitive support under the same clinician model, which works well for patients who want more than a GLP-1 alone.
Best for: Anyone who wants documented lab purity data or plans to add peptide protocols alongside a GLP-1, and is willing to pay a bit more for that.
3. Mochi Health
Mochi is one of the few affordable platforms staffed by board-certified obesity-medicine physicians rather than general practitioners. Compounded semaglutide starts around $99 per month, compounded tirzepatide around $199. The monitoring is heavier than budget-only competitors. You get more clinical check-ins. Not every patient wants that level of contact, but for someone coming in with metabolic complexity, it matters.
Best for: Patients who want obesity-medicine specialist oversight without paying concierge prices.
4. PlushCare
PlushCare charges $19.99 per month for membership, handles same-day telehealth visits, and works with insurance for branded GLP-1s. For anyone who has commercial insurance and just needs a fast prior-auth push, this is a practical, low-friction choice. Branded medications through insurance can drop to near zero out of pocket with manufacturer savings cards.
Best for: Insured patients who want same-day access and a realistic shot at branded Wegovy or Zepbound at low or no cost.
5. Hims & Hers
After the Novo Nordisk settlement in March 2026, Hims & Hers exited compounded GLP-1 products and now sells branded medications only. Injectable Wegovy runs around $299 per month through their platform, oral semaglutide around $249, and Zepbound around $399. With insurance plus a manufacturer savings card, some patients reach $0 to $25. Not the cheapest cash option. Worth it if you specifically want branded and want it bundled with their existing care platform.
Best for: Patients set on branded medication who want a single, familiar telehealth portal.
6. Henry Meds
Henry Meds is cash-pay, no insurance games. Compounded GLP-1s start around $179 to $249 for the first month, with fast shipping in the 24-to-72-hour range. Monitoring is lighter than Mochi, which keeps costs down. Fine for someone self-directed who just wants the medication moving quickly.
Best for: Self-directed patients who want compounded meds shipped fast without a lot of required check-ins.
7. Eden
Eden offers compounded semaglutide at roughly $149 per month, cash-pay, with physician oversight. Straightforward. No coaching add-ons inflating the price. Fewer states than the largest platforms, so check availability first. A solid middle-ground option when the very lowest prices are gone and the patient wants a cleaner setup than a high-volume discount provider.
Best for: Budget-conscious patients who want a simple cash-pay process with no program fees layered on top.
8. Ro Body
Ro’s first month runs about $39, then $74 to $149 monthly, with medications billed separately. They have a dedicated prior-authorization team, which is useful because prior-auth for branded GLP-1s can take weeks without someone pushing it. Ro accepts insurance for branded meds. The separate billing for medication makes the total cost harder to predict upfront, which is the main irritant.
Best for: Patients with insurance who want a provider actively working the prior-auth process on their behalf.
9. Sesame
Sesame operates more like a telehealth marketplace than a dedicated weight-loss program. Annual plans start around $59 per month. Medications are billed separately from the visit cost, so the all-in number depends heavily on what you are prescribed and where you fill it. The flexibility is real though. Good for patients who already have a preferred pharmacy relationship or want to shop prescription pricing independently.
Best for: Price-conscious patients who want telehealth access without being locked into a single-brand medication pipeline.
10. Found
Found charges around $99 per month for platform access plus coaching, with medication costs additional. The coaching component is genuine, not just an automated check-in. If behavioral support is part of what you are looking for alongside medication, Found builds it in rather than selling it as an expensive upgrade. Not the cheapest option when you add the medication cost. But for some patients, the structure helps.
Best for: Patients who want regular behavioral coaching integrated with their medication plan and are willing to pay for both.
A Quick Note on Compounded Medications
The FDA sent warning letters to more than 30 telehealth and compounding firms in early 2026. The regulatory picture around compounded GLP-1s is still shifting. Compounded medications are not FDA-approved. They can be legal and legitimate when dispensed by a properly registered 503A pharmacy, but the category is under real scrutiny. Ask any provider you consider which pharmacy fills your prescription, whether that pharmacy is 503A-registered, and whether testing documentation is available. Those are not unreasonable questions.
Common Questions
Does the Hims & Hers exit from compounded GLP-1s mean other platforms will follow?
Not automatically, but the March 2026 Novo Nordisk settlement set a precedent that other brand manufacturers may reference. Platforms built entirely around compounded semaglutide or tirzepatide are watching the regulatory environment closely. For now, providers like HealthRX, Mochi, and Eden continue operating through 503A pharmacies, though that status can change quickly if FDA enforcement expands.
Is a $99 per month compounded semaglutide from HealthRX actually the same drug as branded Wegovy?
No, and the distinction matters. Compounded semaglutide contains the same active molecule but is not manufactured under the same FDA-oversight process as Wegovy. It comes from a 503A compounding pharmacy, not a licensed pharmaceutical manufacturer. The clinical trial data cited, STEP 1 and SURMOUNT-1, was conducted on FDA-approved branded formulations, not compounded versions.
What does it actually mean that FormBlends publishes HPLC and mass spec results?
HPLC testing measures purity by separating compound components, and mass spec confirms molecular identity. Together they give a reasonable third-party-style check that what is in the vial matches what the label says. Most platforms publish nothing comparable. It does not replace FDA approval, but it is meaningfully more transparent than a certificate of analysis alone.
If I have insurance, which of these providers gives me the best shot at low-cost branded medication?
PlushCare and Ro Body are the strongest options here. PlushCare handles same-day visits and pushes prior authorizations, while Ro has a dedicated prior-auth team that actively follows up. Combining a successful prior-auth with a Novo Nordisk or Eli Lilly savings card can bring Wegovy or Zepbound to $0 to $25 per month for eligible commercially insured patients.
Does Found’s coaching model actually change weight loss outcomes, or is it just a fee add-on?
The evidence for behavioral support alongside GLP-1 medication is real. Studies consistently show better long-term outcomes when medication is paired with structured lifestyle intervention. Whether Found’s specific coaching format delivers that in practice depends on the individual clinician and how engaged the patient is. It is a genuine program feature, not purely a marketing add-on, but results will vary.
Sources
- FDA, compounding pharmacy warning letters and 503A regulatory guidance, 2025-2026
- SURMOUNT-1 trial, tirzepatide efficacy data, published in *New England Journal of Medicine*, 2022
- STEP 1 trial, semaglutide efficacy data, published in *New England Journal of Medicine*, 2021
- Novo Nordisk settlement reporting, March 2026, *Reuters* and *STAT News*
- LegitScript certification registry (public search)
- Individual brand pricing pages, verified Q2 2026